Postoperative atrial fibrillation (POAF), a common complication of cardiac surgery, can increase the morbidity and mortality, as well as the costs of the surgery being preformed. Guidelines recommend the use of β-blockers, amiodarone, or sotalol to decrease the risk of experiencing POAF. However, none of these agents fully protect the patient from POAF, thus newer agents are needed to be used in combination with them. Many different agents have been studied to fit this role and may be grouped into 2 categories: agents with antiarrhythmic activity such as magnesium and polyunsaturated fatty acids and agents with anti-inflammatory activity such as statins and free radical scavengers. Most of these novel agents have been studied in a wide variety of trials; however, some clearly have more effect than others. Although none of these newer agents have the data required to make blanket recommendations for use at this point, given the safety profile and low costs of some, many continue to be evaluated in randomized-controlled trials.
Hogue CH, Creswell LL, Gutterman DD, Fleisher LAEpidemiology, mechanisms, and risks. American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005;128(2 suppl):9S-16S.
2.
Villareal RP , Hariharan R., Liu BC, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43:742-748.
3.
Cresswell LL , Schuessler RB, Rosenbloom M., Cox JLHazards of postoperative atrial arrhythmias . Ann Thorac Surg. 1993 ; 56(3):539-549.
4.
Bradley D., Creswell LL, Hogue CH, Epstein AE, Prystowsky EN, Daoud EGPharmacologic prophylaxis. American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005;128(2 suppl):39S-47S.
5.
Connolly SJ, Cybulsky I., Lamy A., et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the β-blocker length of stay (BLOS) study. Am Heart J. 2003;145(2):226-232.
6.
Patel AA, White CM, Gillespie EL, Kluger J., Coleman CISafety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. Am J Health-Syst Pharm. 2006 ;63(9): 829-837.
7.
Ishii Y., Schuessler RB, Gaynor SL, et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation. 2005;111(22): 2881-2888.
8.
Bruins P., te Velthuis H., Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmias. Circulation. 1997; 96(10):3542-3548.
9.
Gaudino M., Andreotti F., Zamparelli R., et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?Circulation. 2003; 108(suppl 1):11195-11199.
10.
Lertburapa K., White CH, Kluger J., Faheem O., Hammond J., Coleman CIPreoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery . J Thorac Cardiovasc Surg. 2008;135(2):405-411.
11.
Marín F., Pascual DA, Roldán V., et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol. 2006;97(1):55-60.
12.
Mariscalco G., Lorusso R., Klersy C., et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg. 2007; 84(4):1158-1165.
13.
Miceli A., Fino C., Fiorani B., et al. Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ann Throrac Surg. 2009;87(6):1853-1858.
14.
Ozaydin M., Dogan A., Varol E., et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology. 2007;107(2):117-121.
15.
Pan W., Pintar T., Anton J., Lee V., Vaughn WK, Collard CDStatins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110(11 suppl 1):1145-1149.
16.
Patti G., Chello M., Candura D., et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (atorvastatin for the reduction of myocardial dysrhythmias after cardiac surgery) study. Circulation. 2006;114(14):1455-1461.
17.
Song YB, On YK, Kim JH, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery . Am Heart J. 2008;156(2): 373.e9-373.e16.
18.
Virani SS, Nambi J., Razavi M., et al. Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J. 2008;155:541-546.
19.
Carnes CA, Chung MK, Nakayama T., et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res. 2001;89(6):E32-E38.
20.
Eslami M., Badkoubeh RS, Mousavi M., et al. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex Heart Inst J. 2007;34(3):268-274.
21.
Leaf A., Kang JX, Xiao Y.-F, Billman GE, Voskuyl RAThe Antiarrhythmic and anticonvulsant effects of dietary N-3 fatty acids. J Membr Biol. 1999;172(1):1-11.
22.
Mozaffarian D., Psaty BM, Rimm EB, et al. Fish intake and the risk of incident atrial fibrillation. Circulation . 2004;110(4): 368-373.
23.
Calò L. , Bianconi L., Colivicchi F., et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized controlled trial. J Am Coll Cardiol. 2005;45(10): 1723-1728.
24.
Heidarsdottir R., Arnar DO, Skuladottir GV, et al. Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?Europace. 2010;12(3):356-363.
25.
Saravanan P. , Bridgewater B., West AL, O’Neill SC, Calder PC, Davidson NCOmega-3 fatty acid supplementation does not reduce risk of atrial fibrillation following coronary artery bypass surgery: a randomized, double blind, placebo controlled clinical trial. Circ Arrhythm electrophysiol. 2010; 3(1):46-53.
26.
Omega-three fatty acids for the prevention of atrial fibrillation after cardiac surgery. In: Clinicaltrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000-2010. Available from: http://clinicaltrials.gov/ct2/show/NCT00446966
27.
Aglio LS, Stanford GG, Maddi R., Boyd JL 3rd, Nussbaum S., Chernow B.Hypomagnesemia is common following cardiac surgery. J Cardiothrorac Vasc Anesth. 1991;5(3):201-208.
28.
Booth JV, Phillips-Bute B., McCants CB, et al. Low serum magnesium level predicts major adverse cardiac events after coronary artery bypass great surgery. Am Heart J. 2003; 145(6):1108-1113.
29.
Zaman AG, Alamgir F., Richens T., Williams R., Rothman MT, Mills PGThe role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass sugery . Heart. 1997;77(6): 527-531.
30.
Toraman F., Karabulut H., Alhan HC, Dagdelen S., Tarcan S.Magneium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann thorac Surg. 2001;72(4):1256-1262.
31.
Zangrillo A. , Landoni G., Sparicio D., et al. Perioperative magnesium supplementation to prevent atrial fibrillation after off-pump coronary artery surgery: a randomized controlled study. J Cardiothorac Vasc Anesth. 2005;19(6):723-728.
32.
Cook RC, Humphries KH, Gin K., et al. Prophylactic intravenous magnesium sulphate in addition to oral β-blockade does not prevent atrial arrhythmias after coronary artery or vascular heart surgery: a randomized, controlled trial. 2009 ;120(Suppl 2):S163-S169.
33.
Henyan NN, Gillespie EL, White CM, Kluger J., Coleman CIImpact of intravenous magnesium on post-cardiothoracic surgery fibrillation and length of hospital stay: a meta-analysis. Ann Thorac Surg . 2005;80(6):2402-2406.
34.
Miller S., Crystal E., Garfinkle M., Lau C., Lashevsky I., Connolly SJEffects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis . Heart. 2005;91(5):618-623.
35.
Schönbeck U., Libby P.Inflammation, immunity, and HMG-CoA reductiase inhibitors: statins as anti-inflammatory agents?Circulation . 2004;109(21 suppl 1):1118-1126.
36.
Sasa S., Vecht JA, Rao C., et al. Statin therapy may influence the incidence of postoperative atrial fibrillation: what is the evidence?Tex Heart Inst J.2009;36(6):521-529.
37.
Kostapanos MS, Liberopoulos EN, Goudevenos JA, Mikhailidis DP, Elisaf MSDo statins have an antiarrhythmic activity ? Cardiovasc Res. 2007;75(1):10-20.
38.
Patel AA, White CM, Shah SA, Dale KM, Kluger J., Coleman CIThe relationship between statin use and atrial fibrillation. Curr Med Res Opin. 2007;23(5):1177-1185.
39.
Baker WL, Anglade MW, Baker EL, White CM, Kluger J., Coleman CIUse of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. Eur J Cardiothorac Surg.2009;35(3):521-527.
40.
Ozaydin M., Peker O., Erdogan D., et al. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J. 2008; 29(5):625-631.
41.
Wijeysundera DN, Beattie WS, Rao V., Granton JT, Chan CTN-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency . Can J Anesth. 2007;54(11):872-881.
42.
Haase M., Haase-Fielit A., Bagshaw SM, et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med. 2007;35(5): 1324-1331.
43.
El-Hamamsy I., Stevens LM, Carrier M., et al. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg . 2007;133(1):7-12.
44.
Eren N., Cakir O., Oruc A., Kaya Z., Erdinc L.Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass. Perfusion . 2003;18(6):345-350.
45.
Halonen J., Halonen P., Järvinen O., et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. J Am Med Assoc . 2007;297(14): 1562-1567.
46.
Chaney MA, Nikolov MP, Blakeman B., Bakhos M., Slogoff S.Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg . 1998;87(1):27-33.
47.
Chaney MA, Durazo-Arvizu RA, Nikolov MP, Blakeman BP, Bakhos M.Methylprednisolone does not benefit patients undergoing coronary artery bypass grafting and early tracheal extubation. J Thorac Cardiovasc Surg. 2001;121(3):561-569.
48.
Yared JP, Starr NJ, Torres FK, et al. Effects of single dose, post-induction dexamethasone on recovery after cardiac surgery. Ann Thorac Surg. 2000 ;69(5):1420-1424.
49.
Halvorsen P. , Ræder J., White PF, et al. The effect of dexamethasone on side effects after coronary revascularization procedures . Anesth Analg. 2003;96(6):1578-1583.
50.
Baker WL, White CM, Kluger J., Denowitz A., Konecny CP, Coleman CIEffect of perioperative corticosteroid use on the incidence of postcardiothroacic surgery atrial fibrillation and length of stay. Heart Rhythm . 2007;4(4):461-468.
51.
Ho KM, Tan JABenefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation. 2009;119(14):1853-1866.
52.
Whitlock RP , Chan S., Devereaux PJ, et al. Clinical benefit of steroid use in patients undergoin cardiopulmonary bypass: a meta-analysis of randomized trials . Eur Heart J . 2008;29(21):1592-1600.
53.
Kalus JS, Caron MF, White CM, et al. Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery. Am J Cardiol. 2004;94(11):1423-1425.
54.
Cheruku KK, Ghani A., Ahmad F., et al. Efficacy of nonsteroidal anti-inflammatory medications for the prevention of atrial fibrillation following coronary artery bypass graft surgery . Prev Cardiol. 2004;7(1):13-18.
55.
Ruffin RT, Kluger J., Baker WL, Wills SM, White CM, Coleman CIAssociation between perioperative NSAID use and post-cardiothoracic surgery atrial fibrillation, blood transfusions, and cardiovascular outcomes: a nested cohort study from the AF suppression trials (AFIST) I, II and III . Cur Med Res Opin. 2008;24(4):1131-1136.
56.
Nussmeier NA , Whelton AA, Brown MT, et al. Complications of the COX-2 inhibitors parexocib and valdecoxib after cardiac surgery. N Engl J Med . 2005;352(11):1081-1091.
57.
Iravian S., Dudley SCOxidative stress and the pathogenesis of atrial fibrillation. Curr Cardiol Rev. 2006;2(4):247-254.
58.
Anglade MW, Kluger J., White CM, Aberle J., Coleman CIThiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study. Cur Med Res Opin. 2007 ;23(11): 2849-2855.
59.
Berlie HD, Kalus JS, Jaber LAThiazolidinediones and the risk of edema: a meta-analysis. Diabetes Res Clin Pract. 2007;76(2): 279-289.
60.
Nissen SE, Wolski K.Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356(24):2457-2471.
61.
Engelmann MDM , Svendsen JHInflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J. 2005;26(20): 2083-2092.
62.
Jibrini MB, Molnar J., Arora RRPrevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis. Am J Ther. 2008;15(1):36-43.
63.
Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. J Am Med Assoc. 2004; 291(14):1720-1729.
64.
Coleman CI, Makanji S., Kluger J., White CMEffect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothroacic surgery atrial fibrillation . Ann Pharmacother. 2007;41(3):433-437.
65.
White CM, Kluger J., Lertsburapa K., Faheem O., Coleman CIEffect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. Eur J Cardiothorac Surg. 2007;31(5):817-820.
66.
Ozaydin M., Dede O., Varol E., et al. Effect of renin-angiotensin aldosteron system blockers on postoperative atrial fibrillation. Int J Cardiol. 2008;127(3):362-367.
67.
Rodrigo R., Vinay J., Castillo R., et al. Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation. Int J Cardiol.2010;138(3):221-228.
